# FDA Inspection 1200703 - Boston Analytical, Inc. - March 07, 2023

Source: https://www.keypedia.com/records/fda_inspections/boston-analytical-inc/c54ca271-84b7-446c-b5d4-a07d74f2ae1e
Source feed: FDA_Inspections

> FDA Inspection 1200703 for Boston Analytical, Inc. on March 07, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200703
- Company Name: Boston Analytical, Inc.
- Inspection Date: 2023-03-07
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1200703 - 2023-03-07](https://www.keypedia.com/records/fda_inspections/boston-analytical-inc/fa2b833e-3cd4-4874-b593-3fabb733392c)
- [FDA Inspection 1115784 - 2020-01-24](https://www.keypedia.com/records/fda_inspections/boston-analytical-inc/27999c69-291d-43e4-8c15-172499a9e849)
- [FDA Inspection 1076790 - 2019-01-15](https://www.keypedia.com/records/fda_inspections/boston-analytical-inc/5f54247b-be16-4cb3-a026-08b10a7db4db)
- [FDA Inspection 987020 - 2016-09-22](https://www.keypedia.com/records/fda_inspections/boston-analytical-inc/5223548f-867f-4bf3-b6fe-ee06f5971fb9)
- [FDA Inspection 987020 - 2016-09-22](https://www.keypedia.com/records/fda_inspections/boston-analytical-inc/203cb423-2236-4daa-b565-14a75dfb36c8)

Company: https://www.keypedia.com/companies/boston-analytical-inc/a21fce05-8b60-4a91-ac00-217015ac046a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c